Conclusions and clinical perspectives

Date

07 Oct 2016

Session

Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Presenters

Rolf A. Stahel

Authors

R.A. Stahel

Author affiliations

Clinik And Policlinic Of Oncology, Universitätsspital Zürich, 8091 - Zürich/CH

More

Resources

Reserved to ESMO members

Login Join ESMO

Watch the webcast

Resources from the same session

07 Oct 2016

PDL 1 immunohistochemistry laboratory validation

Presenter: Mogens Vyberg

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Presentation

Webcast

07 Oct 2016

PDL 1 Immunohistochemistry clinical validation with the example of thoracic tumours

Presenter: Solange Peters

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Presentation

Webcast

07 Oct 2016

Introduction

Presenter: Peter Schirmacher

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Presentation

Webcast

07 Oct 2016

Beyond immunohistochemistry

Presenter: Ian Cree

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Presentation

Webcast